Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA DR. REDDYS LAB CIPLA/
DR. REDDYS LAB
 
P/E (TTM) x 32.2 19.7 163.5% View Chart
P/BV x 5.2 4.4 116.5% View Chart
Dividend Yield % 0.6 0.6 87.5%  

Financials

 CIPLA   DR. REDDYS LAB
EQUITY SHARE DATA
    CIPLA
Mar-23
DR. REDDYS LAB
Mar-23
CIPLA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,1854,656 25.5%   
Low Rs8523,788 22.5%   
Sales per share (Unadj.) Rs281.91,481.4 19.0%  
Earnings per share (Unadj.) Rs35.1270.7 13.0%  
Cash flow per share (Unadj.) Rs49.7345.7 14.4%  
Dividends per share (Unadj.) Rs8.5040.00 21.3%  
Avg Dividend yield %0.80.9 88.1%  
Book value per share (Unadj.) Rs289.21,389.6 20.8%  
Shares outstanding (eoy) m807.15166.53 484.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.62.8 126.8%   
Avg P/E ratio x29.015.6 185.9%  
P/CF ratio (eoy) x20.512.2 168.0%  
Price / Book Value ratio x3.53.0 115.9%  
Dividend payout %24.214.8 163.7%   
Avg Mkt Cap Rs m822,164703,039 116.9%   
No. of employees `000NANA-   
Total wages/salary Rs m38,30146,466 82.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m227,531246,697 92.2%  
Other income Rs m5,12110,555 48.5%   
Total revenues Rs m232,653257,252 90.4%   
Gross profit Rs m48,07963,860 75.3%  
Depreciation Rs m11,72112,502 93.8%   
Interest Rs m1,0951,428 76.7%   
Profit before tax Rs m40,38460,485 66.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,02915,412 78.0%   
Profit after tax Rs m28,35545,073 62.9%  
Gross profit margin %21.125.9 81.6%  
Effective tax rate %29.825.5 116.9%   
Net profit margin %12.518.3 68.2%  
BALANCE SHEET DATA
Current assets Rs m168,051203,161 82.7%   
Current liabilities Rs m50,33385,721 58.7%   
Net working cap to sales %51.747.6 108.7%  
Current ratio x3.32.4 140.9%  
Inventory Days Days7379 92.5%  
Debtors Days Days7107 6.1%  
Net fixed assets Rs m117,318112,638 104.2%   
Share capital Rs m1,614833 193.8%   
"Free" reserves Rs m231,845230,571 100.6%   
Net worth Rs m233,460231,404 100.9%   
Long term debt Rs m01,278 0.0%   
Total assets Rs m290,067315,799 91.9%  
Interest coverage x37.943.4 87.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.8 100.4%   
Return on assets %10.214.7 69.0%  
Return on equity %12.119.5 62.4%  
Return on capital %17.826.6 66.8%  
Exports to sales %22.652.2 43.4%   
Imports to sales %8.916.8 52.8%   
Exports (fob) Rs m51,516128,803 40.0%   
Imports (cif) Rs m20,20241,484 48.7%   
Fx inflow Rs m64,282128,803 49.9%   
Fx outflow Rs m20,20241,484 48.7%   
Net fx Rs m44,08087,319 50.5%   
CASH FLOW
From Operations Rs m32,37758,875 55.0%  
From Investments Rs m-23,885-41,373 57.7%  
From Financial Activity Rs m-9,583-26,861 35.7%  
Net Cashflow Rs m-968-9,073 10.7%  

Share Holding

Indian Promoters % 13.4 26.7 50.4%  
Foreign collaborators % 20.0 0.0 -  
Indian inst/Mut Fund % 50.0 47.3 105.8%  
FIIs % 25.7 28.6 89.9%  
ADR/GDR % 0.0 15.3 -  
Free float % 66.5 58.0 114.7%  
Shareholders   425,731 257,794 165.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    DIVIS LABORATORIES    ZYDUS LIFESCIENCES    MANKIND PHARMA    SUPRIYA LIFESCIENCE     


More on Cipla vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs Dr. Reddys Share Price Performance

Period Cipla Dr. Reddys S&P BSE HEALTHCARE
1-Day 1.94% 1.78% 1.18%
1-Month 1.25% -4.23% -0.75%
1-Year 68.02% 35.93% 61.82%
3-Year CAGR 22.53% 10.85% 18.16%
5-Year CAGR 23.24% 17.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.5% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 8.5 per share. This amounted to a Dividend Payout ratio of 24.2%.

Dr. Reddys paid Rs 40.0, and its dividend payout ratio stood at 14.8%.

You may visit here to review the dividend history of Cipla, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.